Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain

Lack of association between the −759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients

(2010) Y.-M. Park et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain

(2010) Palmiero Monteleone et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

(2010) Arun K Tiwari et al.   NEUROPSYCHOPHARMACOLOGY

Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients

(2010) Young-Min Park et al.   Psychiatry Investigation

G-protein β3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients

(2009) Young-Min Park et al.   Psychiatry Investigation

Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations

(2008) Michael Benzinou et al.   HUMAN MOLECULAR GENETICS

Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats

(2008) Jenny L. Wiley et al.   NEUROPHARMACOLOGY

Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain

(2007) Seung-Gul Kang et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY